Literature DB >> 15844715

Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?

Keith L E Dear1, Marinos Elia, John O Hunter.   

Abstract

Abnormal fermentation may be an important factor in irritable bowel syndrome (IBS). Gastroenteritis or antibiotic therapy may damage the colonic microflora, leading to increased fermentation and the accumulation of gas. Gas excretion may be measured by whole-body calorimetry but there has only been one such study on IBS to date. We aimed to assess the relationship between IBS symptoms and fermentation rates in IBS. A purpose-built, 1.4-m3, whole-body calorimeter was used to assess excretion of H2 and CH4 in IBS subjects while consuming a standard diet and, again, after open randomization on either the standard diet together with the antibiotic metronidazole or a fiber-free diet to reduce fermentation. Metronidazole significantly reduced the 24-hr excretion of hydrogen (median value compared to the control group, 397 vs 230 ml/24 hr) and total gas (H2 + CH4; 671 vs 422 ml/min) and the maximum rate of gas excretion (1.6 vs 0.8 ml/min), as did a no-fiber polymeric diet (hydrogen, 418 vs 176 ml/min; total gas, 564 vs 205 ml/min; maximum rate of gas excretion, 1.35 vs 0.45 ml/min), with a significant improvement in abdominal symptoms. IBS may be associated with rapid excretion of gaseous products of fermentation, whose reduction may improve symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844715     DOI: 10.1007/s10620-005-2570-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Antibiotics increase functional abdominal symptoms.

Authors:  P R Maxwell; E Rink; D Kumar; M A Mendall
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

2.  Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress.

Authors:  L V Holdeman; I J Good; W E Moore
Journal:  Appl Environ Microbiol       Date:  1976-03       Impact factor: 4.792

3.  Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome.

Authors:  H K Bradley; G M Wyatt; C E Bayliss; J O Hunter
Journal:  J Med Microbiol       Date:  1987-02       Impact factor: 2.472

4.  Relationships between hydrogen (H2) and methane (CH4) production in man.

Authors:  A Bjørneklett; E Jenssen
Journal:  Scand J Gastroenterol       Date:  1982-11       Impact factor: 2.423

5.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11

6.  Different actions of neomychin and metronidazole on breath hydrogen (H2) exhalation.

Authors:  B Lembcke; M Hönig; W F Caspary
Journal:  Z Gastroenterol       Date:  1980-03       Impact factor: 2.000

7.  Abnormal colonic fermentation in irritable bowel syndrome.

Authors:  T S King; M Elia; J O Hunter
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

8.  Functional bowel disorders in apparently healthy people.

Authors:  W G Thompson; K W Heaton
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

9.  Wheat fibre and irritable bowel syndrome. A controlled trial.

Authors:  A P Manning; K W Heaton; R F Harvey
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321

10.  Alternative pathways for hydrogen disposal during fermentation in the human colon.

Authors:  G R Gibson; J H Cummings; G T Macfarlane; C Allison; I Segal; H H Vorster; A R Walker
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

View more
  22 in total

Review 1.  Techniques used to characterize the gut microbiota: a guide for the clinician.

Authors:  Marianne H Fraher; Paul W O'Toole; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-27       Impact factor: 46.802

2.  Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora?

Authors:  Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 3.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

4.  Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome.

Authors:  Bruno P Chumpitazi; Emily B Hollister; Numan Oezguen; Cynthia M Tsai; Ann R McMeans; Ruth A Luna; Tor C Savidge; James Versalovic; Robert J Shulman
Journal:  Gut Microbes       Date:  2014-01-27

5.  Current gut-directed therapies for irritable bowel syndrome.

Authors:  Howard Y Chang; Eoin C Kelly; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

6.  Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.

Authors:  Iris Posserud; Per-Ove Stotzer; Einar S Björnsson; Hasse Abrahamsson; Magnus Simrén
Journal:  Gut       Date:  2006-12-05       Impact factor: 23.059

Review 7.  Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.

Authors:  Yehuda Ringel; Nitsan Maharshak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

Review 8.  Intestinal microbiota and its role in irritable bowel syndrome (IBS).

Authors:  Lena Ohman; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2013-05

Review 9.  Fructose-sorbitol malabsorption.

Authors:  Fernando Fernández-Bañares; Maria Esteve; Josep M Viver
Journal:  Curr Gastroenterol Rep       Date:  2009-10

10.  Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome.

Authors:  Jacqueline S Barrett; Kim E K Canale; Richard B Gearry; Peter M Irving; Peter R Gibson
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.